Nuvation Bio Inc. Class A Common Stock vs Pan American Silver Corp. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B), while Pan American Silver Corp. Common Stock trades at $46.32 (market cap $18.72B). The key difference: Pan American Silver Corp. Common Stock is far larger — about 10.8× Nuvation Bio Inc. Class A Common Stock's market cap, and Pan American Silver Corp. Common Stock pays a 1.62% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Pan American Silver Corp. Common Stock for 1 Days on average.
| NUVB | PAAS | |
|---|---|---|
Market Cap | $1.74B | $18.72B |
Volume | 9,289,619 | 2,957,838 |
Sector | Health | Basic Materials |
52-Week High | $9.54 | $68.70 |
52-Week Low | $3.41 | $33.20 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $1.33B | $17.86B |
Dividend Yield | — | 1.62% |
Trailing returns across standard periods
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Pan American Silver is a mining company focused on silver and gold production in the Americas. It also explores and develops precious metals properties.
Read more on PAAS →